Home / Canadian Health Blog
Health information you can trust
The Canadian Health Blog
Health information, not medical advice. Always speak with your own doctor.
Filtered
Overweight and Obesity
15 articlesDiabetes44Overweight and Obesity37Infectious Diseases30Cardiovascular28Neurological & Neurodegenerative23Arthritis & Joint Pain21Digestive Health19Type 2 Diabetes18COVID-1915Cold & Flu13Depression13Headaches & Migraines12Alzheimer’s & Dementia11Autoimmune Diseases11Asthma10Urinary Incontinence10Chronic Obstructive Pulmonary Disease (COPD)9Influenza (Flu)9Overactive Bladder9High Cholesterol (Hyperlipidemia)8Osteoarthritis7Kidney and Liver Diseases6Stress Incontinence6Breast Cancer5
GLP-1 Agonists ExplainedDiabetesRetatrutide: What New Trial Results Mean for Weight Loss and DiabetesSep 30, 2026 · 4 min read
DiabetesWeight Often Returns After Stopping GLP-1 Weight Loss Drugs, Study FindsMar 11, 2026 · 2 min read
DiabetesRoche Advances New Weight Loss Drug After Promising Trial ResultsJan 28, 2026 · 2 min read
OsteoarthritisEli Lilly’s New Obesity Drug Shows Powerful Weight Loss, But Side Effects Raise ConcernsDec 15, 2025 · 1 min read
DiabetesNew Diabetes Pill Shows Ozempic-Level Weight Loss in New StudyDec 10, 2025 · 2 min read
GLP-1 Agonists ExplainedDiabetesGLP-1 Agonists: Frequently Asked QuestionsNov 18, 2025 · 4 min read
GLP-1 Agonists ExplainedFatty Liver Disease (MASLD/NAFLD)GLP-1 Agonists: Looking to the FutureNov 12, 2025 · 3 min read
GLP-1 Agonists ExplainedCardiovascularGLP-1 Agonists: What They Are & What Makes Them UniqueNov 4, 2025 · 4 min read
DiabetesMounjaro Shows Promise for Kids and Teens with Type 2 DiabetesSep 18, 2025 · 1 min read
DiabetesLilly’s Oral Weight Loss Drug Shows Strong Results in Diabetes PatientsAug 27, 2025 · 1 min read
CardiovascularWegovy Wins FDA Approval for Severe Liver Disease MASHAug 20, 2025 · 2 min readReady when you are
See which studies you may qualify for
About five minutes. Free, and no obligation to take part.
The Canadian Health Newsletter
Health research, explained once a month
New studies and plain-language articles from our health library.
Study alerts: an email only when a matching study opens. Community: our research team may contact you about studies that may fit. Join the community